Results 121 to 130 of about 38,213 (313)
Delayed Gastric Bleeding in a Patient With Chronic Myeloid Leukemia: A Case of Post‐Biopsy Bleeding
DEN Open, Volume 7, Issue 1, April 2027.The presence of underlying conditions, particularly malignancies such as myeloproliferative disorders, may increase the risk of delayed bleeding following gastric mucosal biopsy, and similar cases warrant careful accumulation and evaluation in future. ABSTRACT A 76‐year‐old man was referred to our hospital for evaluation of anemia.
Yoko Kosaka +3 more
wiley +1 more source
Features of complex therapy of hemorrhagic fever with renal syndrome against the background of liver damage [PDF]
Терапевтический архивAim. To evaluate the effectiveness of hepatoprotective support in patients with hemorrhagic fever with renal syndrome (HFRS) with cytolytic syndrome by using the combined drug Remaxol®. Materials and methods.
Andrey A. Shuldyakov +3 more
doaj +1 more source
Successful Treatment of Recurrent Hematometra With Ethanol Sclerotherapy: A Case Report
Clinical Case Reports, Volume 14, Issue 6, June 2026.ABSTRACT To our knowledge, this case report is the first to show that ethanol sclerotherapy can safely and effectively resolve recurrent hematometra caused by postradiotherapy stenosis and recurrent cervical cancer. For patients with poor overall condition in whom cervical drainage is not feasible, this minimally invasive approach may serve as a ...
Kojiro Tanabe +3 more
wiley +1 more source
Coagulopathy in patients with hemorrhagic fever with renal syndrome [PDF]
Journal of Korean Medical Science, 1987 Hemorrhagic fever with renal syndrome in Korea (Korean hemorrhagic fever) is an acute viral disease characterized by fever, hemorrhage and renal failure. In Korean patients, the disease manifests more distinctive bleeding tendencies than those of hemorrhagic fever with renal syndrome found in western countries. To investigate the nature and role of the
openaire +2 more sources
Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.ABSTRACT While the efficacy of canakinumab, an anti‐interleukin‐1β monoclonal antibody, is well‐established, its safety profile, particularly across different age groups, remains inadequately explored. Using the FDA Adverse Event Reporting System (FAERS) database, this study evaluated postmarketing safety by analyzing adverse event (AE) reports from ...
Youyang Wang +3 more
wiley +1 more source
Cardio-renal syndrome: perspectives of research in infectious diseases
Терапевтический архивClinical and prognostic significance of cardio-renal syndrome in various infectious diseases are discussed. Incidence and prognosis, as well as pathogenesis of cardio-renal syndrome in patients with infectious diseases, admitted to ICU of infectious ...
Viktor V. Maleev +3 more
doaj +1 more source
Thrombocytopenia and endothelial dysfunction in hemorrhagic fever with renal syndrome
Журнал инфектологии, 2018 Purpose: to estimate the content of platelets and sP-selectin in patients with different severity of Hemorrhagic Fever with Renal Syndrome. Materials and methods: we have conducted the clinical and laboratory examination of 220 patients with Hemorrhagic ...
G. A. Mukhetdinova +4 more
doaj +1 more source
Acute Hemorrhagic Edema of Infancy [PDF]
, 2016 Acute Hemorrhagic Edema of Infancy is a small vessel leucocytoclastic vasculitis affecting young infants. It is characterized by large, target-like, macular to purpuric plaques predominantly affecting the face, ear lobes and extremities.
Amaro, C +3 more
core +1 more source
International Journal of Laboratory Hematology, Volume 48, Issue 3, Page 521-530, June 2026.ABSTRACT Hematologic emergencies are urgent health conditions which result in significant mortality and morbidity unless timely therapeutic measures are taken. Therapeutic success depends on their timely and accurate recognition by hematology laboratory services.
Ganna Shestakova +2 more
wiley +1 more source
Oncologic Emergencies: Immune-Based Cancer Therapies and Complications [PDF]
, 2020 Cancer therapies have undergone several recent advancements. Current cancer treatments include immune-based therapies comprised of checkpoint inhibitors, and adoptive immunotherapy; each treatment has the potential for complications that differ from ...
Brém, Elizabeth +2 more
core